Prognostic factors for the survival of Taiwanese breast cancer patients

Journal of the Formosan Medical Association

Volumn 101, Issue 2, 2002, Pages 98-103

  Chie, Wei Chu ^a   Chang, Shu Hui ^a   Huang, Chiun Sheng ^a   Tzeng, Shinn Jia ^a   Chen, Jen Hau ^a   Fan, Bih Yuh ^a   Chang, King Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INFILTRATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; PREDICTION; PROBABILITY; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; TAIWAN; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TAIWAN;

EID: 0036302191     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Prognostic factors in breast cancer
2. Current role of the surgeon in collaborating with medical oncologists
3. Primary chemotherapy
4. Conventional adjuvant chemotherapy
5. Conventional adjuvant hormonal therapy
6. Carcinoma of the breast
7. Factors affecting local or regional recurrence in breast cancer
8. Correlation between tumor angiogenesis and metastasis in breast cancer
9. Immunohistochemical analyses of p53 protein expression in breast cancers in Taiwan: A clinicopathologic study
10. Regression models and life-tables
11. Nonparametric estimation from incomplete observations
12. Survival of Cancer Patients in Europe: The EUROCARE-2 Study
13. Relationship among outcome, stage of disease and histologic grade in 22,616 cases of breast cancer
14. A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumor progression in breast cancer
15. Markov chain model for progression of breast cancer. Part I: Tumor attributes and the preclinical screen-detectable phase
16. Markov chain model for progression of breast cancer. Part II: Prediction of outcomes for different screening regimes